Form 4: Pfizer SVP & Controller Sells Shares for Tax Obligations

Pfizer's SVP & Controller, Jennifer B. Damico, disposed of 655 shares of common stock to cover tax obligations related to vested restricted stock units.

Summary

• Jennifer B. Damico, SVP & Controller of Pfizer Inc. (PFE), reported a disposition of common stock.
• The transaction involved 655 shares of Pfizer common stock.
• The shares were disposed of on February 27, 2026, at a price of $27.65 per share.
• The disposition was made to satisfy tax obligations upon the vesting of restricted stock units, including dividend equivalents thereon.
• Following this transaction, Jennifer B. Damico beneficially owns 12,041 shares of Pfizer common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine administrative transaction related to executive compensation and tax obligations, not indicative of a change in company fundamentals or management's confidence.

Positives

• The underlying event for the disposition was the vesting of restricted stock units, indicating earned compensation for the executive.

Negatives

• The disposition of shares is a routine tax-related event and does not inherently signal a negative outlook on the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Pfizer's future outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving the disposition of shares to cover tax liabilities upon the vesting of equity awards, are common and generally considered routine administrative events within the pharmaceutical industry and broader corporate landscape. Such transactions typically do not reflect a change in management's sentiment towards the company's prospects.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction by an executive to cover tax liabilities, not a sale driven by a change in investment sentiment.
• Employees: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations arising from vested equity compensation. Such transactions are common and do not typically reflect a change in the company's fundamental outlook or the executive's confidence. Therefore, it provides no new information that would warrant a change in an investor's existing position or recommendation for Pfizer stock.

Keywords

Pfizer, PFE, Insider Transaction, Form 4, Stock Sale, Executive Compensation, Tax Withholding, Restricted Stock Units